细菌细胞外囊泡的工程策略和生物医学应用
Xuying Liang1, Qianbei Li1, Lei Zheng1
1Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Biomaterials translational
|November 5, 2025
概括
细菌细胞外囊泡 (BEVs) 具有治疗潜力,但需要工程来克服毒性并改善抗原显示以供临床使用. 在BEV工程策略的进步正在为更广泛的生物医学应用铺平道路.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 微生物学 微生物学
背景情况:
- 细菌细胞外囊泡 (BEVs) 是纳米级囊泡,具有固有的治疗潜力和药物递送能力.
- 它们的稳定结构和自然载荷使它们对生物医学应用具有吸引力.
- 临床翻译受到诸如抗原性,毒性和快速清除等挑战的限制.
研究的目的:
- 审查工程细菌细胞外囊泡 (BEVs) 的最新进展.
- 为了解决阻碍BEVs临床转换的局限性.
- 探索工程 BEVs 的治疗应用.
主要方法:
- 讨论将外来货物装载到BEV中的策略.
- 突出排毒方法以减少BEV毒性.
- 审查工程 BEV 对各种疾病的应用进展.
主要成果:
- 工程 BEV 通过改善货物载荷和降低毒性来证明增强的治疗潜力.
- 临床前研究表明,在治疗传染病和癌症方面有前途.
- 工程策略对于克服本地电动汽车的局限性至关重要.
结论:
- BEV工程为治疗应用和药物输送提供了巨大的潜力.
- 需要进一步的研究来解决临床翻译的安全性,标准化和可扩展性.
- 优化排毒,标准化和生产方法是未来成功的关键.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Microorganisms in Medicine and Therapeutics
925
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
925


